Please login to the form below

Not currently logged in
Email:
Password:

PureTech Health appoints new chief financial officer

Joep Muijrers joins the biopharma from Life Sciences Partners

Joep MuijrersClinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of Joep Muijrers.

Muijrers most recently served as a partner and portfolio manager at Life Sciences Partners, a trans-Atlantic investor group with an exclusive focus on the life science industry.

During his 11 years at the company, Muijrers’ responsibilities saw him help several companies strengthen its biopharmaceutical status.

Daphne Zohar, founder and chief executive officer of PureTech Health, said: “We are delighted to have Joep join PureTech Health and bring his diverse experience in life sciences and impressive track record of significant value creation to our team as we enter this next important phase of our growth.”

Muijrers has worked with pharmaceutical clients such as Kite Pharma, Ablynx and Juno Therapeutics, and said: “I am thrilled to join PureTech Health, one of the most exiciting and unique biopharma companies I have come across in my career.”

In his new role, Muijrers will be take the helm of all aspects of the company’s finances, including capital markets strategy and execution, driving monetisation events for growth stage affiliates, strategic and financial planning and financial reporting.

25th April 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

3 reasons why clinical trials will thrive in 2021
It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...

Infographics